U.S. Markets closed

Warren Buffett dumps IBM, boosts stakes in Monsanto and Teva Pharmaceuticals

Warren Buffett’s Berkshire Hathaway (BRK-ABRK-B) stock moves for the first quarter are out.

The “Oracle of Omaha” filed his firm’s 13-F filing on Tuesday. Funds of a certain size are required to disclose their long equity holdings in these regulatory filings. They come out 45 days after the end of each quarter.

During the first quarter, Berkshire Hathaway’s top buys included Apple (AAPL), Monsanto (MON), and Teva Pharmaceuticals (TEVA).

Berkshire Hathaway CEO Warren Buffett’s latest stock moves include Apple, Monsanto, and Teva Pharmaceuticals REUTERS/Rick Wilking/File Photo

Berkshire added nearly 75 million shares of Apple, bringing the entire stake to just over 239.5 million shares, a position valued at more than $44.6 billion as of today’s close.

Berkshire boosted its position in Monsanto by 62%, snapping up another 7.26 million shares of Monsanto. Berkshire last held 18.97 million shares of Monsanto.

Berkshire also added 21.6 million more shares of Teva Pharmaceuticals, bringing its entire stake to 40.54 million shares.

Meanwhile, Berkshire trimmed 1.7 million shares of Wells Fargo (WFC). Still, the bank remained Berkshire’s No. 2 largest equity position with 456.5 million shares still remaining in the position.

Other areas in the portfolio that were trimmed include Phillips 66 (PSX), Charter Communications (CHTR), Liberty Global (LBTYA). Berkshire also trimmed United Continental (UAL) by 1% and added a little more to its Delta Airlines position (DAL).

Berkshire exited its entire position in IBM (IBM), selling the remaining 2.05 million shares.

Julia La Roche is a finance reporter at Yahoo Finance. Follow her on Twitter.